Skip to content

Clinical trials

Completed Breast Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Hong Kong Clear all

68 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20031
20041
20066
20075
20084
20098
20102
20115
20124
20132
20145
20155
20162
20172
20182
20195
20212
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche15
Novartis Pharmaceuticals14
Puma Biotechnology, Inc.7
Pfizer4
The University of Hong Kong4
GlaxoSmithKline3
AstraZeneca2
Boehringer Ingelheim2
Genentech, Inc.2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms68
Neoplasm Metastasis7
Neoplasms5
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Kidney Neoplasms2
Sleep Initiation and Maintenance Disorders2
Adenoma, Islet Cell1
Anemia1

Trials

Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.